InvestorsHub Logo
Followers 33
Posts 1923
Boards Moderated 1
Alias Born 08/02/2019

Re: williamssc post# 402698

Friday, 05/03/2024 9:29:32 AM

Friday, May 03, 2024 9:29:32 AM

Post# of 403090

I would think an effective new anti-fungal combination of Bril + Caspofungin would be of great interest to BP


Yes. In particular this one: "Caspofungin (brand name Cancidas) is a lipopeptide antifungal drug from Merck & Co., Inc."
https://en.wikipedia.org/wiki/Caspofungin#:~:text=Caspofungin%20(INN%3B%20brand%20name%20Cancidas,%26%20Co.%2C%20Inc..
Because of this: "Caspofungin is a drug used to treat several types of fungal infections. Resistance to caspofungin is a huge problem, especially in those that are immunocompromised."
https://www.futuremedicine.com/doi/10.2217/fmb-2023-0236
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News